We are live on ! Find out more
2L

22NW LP Portfolio holdings

AUM $146M
1-Year Est. Return 29.83%
This Fund
S&P 500
This Quarter Est. Return
+12.51%
1 Year Est. Return
+29.83%
3 Year Est. Return
+131.37%
5 Year Est. Return
+199.25%
10 Year Est. Return
AUM
$88.1M
AUM Growth
+$12.3M
Cap. Flow
+$5.34M
Cap. Flow %
6.06%
Top 10 Hldgs %
72.25%
Holding
35
New
11
Increased
7
Reduced
3
Closed
7

Sector Composition

Rank Sector Weight
1 Consumer Staples 26.93%
2 Industrials 16.02%
3 Healthcare 14.49%
4 Consumer Discretionary 11.47%
5 Technology 11.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDRX
26
DELISTED
Veradigm Inc. Common Stock
MDRX
$432K 0.49%
+43,976
New +$463K
ASIX icon
27
AdvanSix
ASIX
$567M
$417K 0.47%
+20,895
New +$457K
AIOT
28
PowerFleet Inc
AIOT
$500M
$147K 0.17%
22,590
-344,793
-94% -$2.08M
DLTR icon
29
Dollar Tree
DLTR
$23.1B
-12,000
Closed -$1.37M
DXC icon
30
DXC Technology
DXC
$1.63B
-24,356
Closed -$719K
PRTS icon
31
CarParts.com
PRTS
$42.8M
-43,433
Closed -$673K
TAC icon
32
TransAlta
TAC
$4.34B
-148,500
Closed -$965K
TSLA icon
33
PUT
Tesla
TSLA
$1.24T
-207,000
Closed -$148K
PCOM
34
DELISTED
Points.com Inc. Common Shares
PCOM
-41,792
Closed -$458K
SBBP
35
DELISTED
Strongbridge Biopharma plc.
SBBP
-804,410
Closed -$1.92M

Similar funds

22NW LP's Q4 2019 Portfolio in Review

As of Q4 2019, 22NW LP held 35 positions worth $88.1M, up 16% from $75.8M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

22NW LP deployed $5.34M of net new capital in Q4 2019, opening 11 new positions and adding to 7 existing holdings. Its largest new stake was Medifast: 15,961 shares worth $1.75M.

By sector, the portfolio is most concentrated in Consumer Staples at 27% of assets, up from 23% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was PowerFleet Inc, an estimated $2.08M trimmed.

  • 22NW LP's largest Q4 2019 buy was Medifast: 15,961 shares worth $1.75M.
  • 22NW LP added most to Gulf Island Fabrication in Q4 2019, an estimated $1.15M increase.
  • 22NW LP's biggest Q4 2019 reduction was PowerFleet Inc, cutting an estimated $2.08M.
  • 22NW LP fully exited Strongbridge Biopharma plc. in Q4 2019, selling an estimated $1.92M.
  • 22NW LP's ten largest holdings make up 72% of its $88.1M portfolio in Q4 2019.
  • 22NW LP opened 11 new positions and closed 7 in Q4 2019.
  • 22NW LP's portfolio value rose 16% quarter-over-quarter to $88.1M.

Based on 22NW LP's 13F filing for Q4 2019, filed 14 Feb 2020.